INHCC Mission


The mission of the International NeuroHIV Cure Consortium (INHCC) is to provide cutting-edge investigation and expertise in central nervous system (CNS) aspects of HIV infection relevant to pathogenesis, treatment, and HIV remission, or 'cure.'  Beginning with our first project in 2009 to evaluate the neurological implications of acute HIV infection, the group has grown to now encompass investigation into a broad array of early infection and cure strategy work. The consortium was established in 2014 to facilitate scientific exchange among investigators in a diverse array of fields and to leverage all aspects of the research portfolio  through multidisciplinary studies during acute and chronic HIV infection and HIV remission studies.​

NeuroHIV-Related News of Note
 British HIV Assn (BHIVA): 'Best of CROI' Feedback Meetings
View recording of BHIVA's CROI reports
11th International AIDS Society (IAS) Conference : Berlin, Germany
July 18-21, 2021 Hybrid setting (onsite & virtual)

Consortium Leadership
Serena Spudich MD, MA                        
Yale University     
Denise Hsu BSc (Med) MBBS, PhD
US Military HIV Research Program (MHRP)                                                     
    
                                                                                                                        
INHCC work is sponsored by NIH, NIMH, NINDS, NIAID, and the Walter Reed Army Institute of Research (WRAIR)